The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).

Last year, South Africa witnessed hydrogen fuel cell electric vehicle (FCEV) mobility in Johannesburg when B20 and G20 ...

In order to reach their full potential, companies need to be able to balance being a ‘great company and a ‘great stock,’ ...

South Africa’s stronger public finances have given the county a sizable cushion to absorb external shocks — such as the ...

JSE-listed mining and chemicals multinational AECI posted revenue of R32.1-billion for the year ended December 31, 2025, ...

Extinction occurs when a species can no longer survive or be sustained in its environment, or when its environment rapidly ...

Quilter plc preliminary results for the year ended 31 December 2025 and final dividend Quilter reports record flows, adjusted ...

Abstract: A novel multibeam pattern synthesis method is presented for the transmitter of millimeter-wave multibeam phased arrays. By utilizing the multi-objective genetic optimization algorithm, the ...

Correspondence to Professor Dominic Y Leung, Cardiology, University of New South Wales, Liverpool Hospital, Sydney, NSW 2052, Australia; d.leung{at}unsw.edu.au Clinical trials traditionally aim to ...

A massive build in U.S. oil stocks couldn't drag oil lower ahead of the next round of talks between the United States and Iran. Geopolitical risk premium is elevated and there is significant call skew ...